Dawn Thomas

1.0k total citations
31 papers, 807 citations indexed

About

Dawn Thomas is a scholar working on Immunology, Transplantation and Hematology. According to data from OpenAlex, Dawn Thomas has authored 31 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 8 papers in Transplantation and 7 papers in Hematology. Recurrent topics in Dawn Thomas's work include Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (14 papers) and Renal Transplantation Outcomes and Treatments (8 papers). Dawn Thomas is often cited by papers focused on Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (14 papers) and Renal Transplantation Outcomes and Treatments (8 papers). Dawn Thomas collaborates with scholars based in United States, Canada and Germany. Dawn Thomas's co-authors include Vincent K. Tuohy, Richard M. Ransohoff, H. Elizabeth Shick, Marie Tani, Mark H. Stoler, Melinda L. Estes, Thomas A. Hamilton, Jennifer Major, Medhat Askar and Edward J. Ball and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and The FASEB Journal.

In The Last Decade

Dawn Thomas

29 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn Thomas United States 12 441 237 222 159 82 31 807
Heping Xu China 12 900 2.0× 140 0.6× 150 0.7× 178 1.1× 66 0.8× 23 1.2k
Ángela Ballesteros United States 16 587 1.3× 174 0.7× 90 0.4× 338 2.1× 33 0.4× 26 1.0k
Shinichi Esaki Japan 13 184 0.4× 357 1.5× 38 0.2× 99 0.6× 131 1.6× 27 660
Terry Fang United States 14 986 2.2× 246 1.0× 193 0.9× 873 5.5× 49 0.6× 22 1.8k
Riccardo Cassiani‐Ingoni United States 13 293 0.7× 190 0.8× 125 0.6× 183 1.2× 63 0.8× 16 1.0k
Gregory R. Ryan Australia 7 903 2.0× 310 1.3× 189 0.9× 662 4.2× 69 0.8× 8 1.5k
Klaus‐Dieter Preuss Germany 20 414 0.9× 161 0.7× 18 0.1× 401 2.5× 51 0.6× 50 954
Jörg Schönheit Germany 9 604 1.4× 157 0.7× 65 0.3× 440 2.8× 56 0.7× 9 995
Yuichi Wakabayashi Japan 14 244 0.6× 254 1.1× 25 0.1× 592 3.7× 122 1.5× 47 941
L. Ballard United States 16 199 0.5× 158 0.7× 92 0.4× 455 2.9× 300 3.7× 53 1.2k

Countries citing papers authored by Dawn Thomas

Since Specialization
Citations

This map shows the geographic impact of Dawn Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Thomas more than expected).

Fields of papers citing papers by Dawn Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Thomas. The network helps show where Dawn Thomas may publish in the future.

Co-authorship network of co-authors of Dawn Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn Thomas. A scholar is included among the top collaborators of Dawn Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn Thomas. Dawn Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, Oliver, Matteo S. Carlino, Craig Underhill, et al.. (2024). 713MO Nivolumab and ipilimumab combination treatment in advanced gynaecological clear cell cancers: Results from the phase II MoST-CIRCUIT trial. Annals of Oncology. 35. S546–S547. 5 indexed citations
2.
Zhang, Aiwen, Chi Chiu Wang, Tharindumala Abeywardana, et al.. (2024). Using single antigen specificity magnetic beads for the isolation of specific antibodies against HLA antigens. HLA. 103(4). e15490–e15490. 1 indexed citations
3.
Zhang, Aiwen, Dawn Thomas, David Bosler, et al.. (2024). Engraftment and Measurable Residual Disease Monitoring after Hematopoietic Stem Cell Transplantation. Journal of Molecular Diagnostics. 26(4). 233–244. 2 indexed citations
4.
Thomas, Dawn. (2022). Concierge Mobile Physical Therapy and Wellness. Home Healthcare Now. 40(2). 110–111. 1 indexed citations
6.
Patel, Sagar S., Lisa Rybicki, Dawn Thomas, et al.. (2019). Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation. Hematology/Oncology and Stem Cell Therapy. 13(1). 32–39. 6 indexed citations
9.
Gandhi, Manish J., Deborah Ferriola, Curt Lind, et al.. (2017). Assessing a single targeted next generation sequencing for human leukocyte antigen typing protocol for interoperability, as performed by users with variable experience. Human Immunology. 78(10). 642–648. 9 indexed citations
11.
Aiken, Taylor, Ari Garber, Dawn Thomas, et al.. (2016). Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C. PLoS ONE. 11(11). e0166998–e0166998. 13 indexed citations
13.
Viny, Aaron D., et al.. (2011). Description of two new MICA alleles: MICA*058 and MICA*002:03. Tissue Antigens. 79(2). 144–145. 1 indexed citations
14.
Askar, Medhat, Robin K. Avery, Rebecca Corey, et al.. (2009). Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients1. Liver Transplantation. 15(11). 1557–1563. 18 indexed citations
15.
16.
Park, Hyun-Min, Justin M. Johnson, Cengiz Z. Altuntas, et al.. (2006). Increased Frequencies of Cochlin-Specific T Cells in Patients with Autoimmune Sensorineural Hearing Loss. The Journal of Immunology. 177(6). 4203–4210. 80 indexed citations
17.
Yamani, Mohamad H., Daniel Cook, E. René Rodríguez, et al.. (2006). Increased Expression of Angiotensin II Type 1 Receptor (AGTR1) in Heart Transplant Recipients With Recurrent Rejection. The Journal of Heart and Lung Transplantation. 25(11). 1283–1289. 19 indexed citations
18.
Paul, Pascale, et al.. (2001). Resolution of cis‐trans ambiguities between HLA‐DRB1 alleles using single‐strand conformation polymorphisms and sequencing. Tissue Antigens. 57(4). 300–307. 11 indexed citations
19.
Tuohy, Vincent K., Dawn Thomas, Talat Haqqi, Min Yu, & Justin M. Johnson. (1995). Determinant-Regulated Onset of Experimental Autoimmune Encephalomyelitis: Distinct Epitopes of Myelin Proteolipid Protein Mediate Either Acute or Delayed Disease in SJL/J Mice. Autoimmunity. 21(3). 203–213. 10 indexed citations
20.
Tuohy, Vincent K. & Dawn Thomas. (1995). Sequence 104–117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice. Journal of Neuroimmunology. 56(2). 161–170. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026